Showing results (661-670 of 6,300) with videos related to
Sort By:
Pageof 630
Diabetes, Obesity & Metabolism|June 27, 2007
Pioglitazone attenuates fatty acid-induced oxidative stress and apoptosis in pancreatic beta-cellsY Saitoh, C Chun-ping, K Noma, et al.Diabetes, Obesity & Metabolism|June 27, 2007
Efficacy and safety of the dipeptidyl peptidase-4 inhibitor, sitagliptin, in patients with type 2 diabetes mellitus inadequately controlled on glimepiride alone or on glimepiride and metforminK Hermansen, M Kipnes, E Luo, et al.Diabetes, Obesity & Metabolism|May 10, 2007
Monogenic diabetes: implications for therapy of rare types of diseaseMaciej T Malecki, Wojciech MlynarskiDiabetes, Obesity & Metabolism|May 11, 2007
Eplerenone improves prognosis in postmyocardial infarction diabetic patients with heart failure: results from EPHESUSJ H O'Keefe, H Abuissa, B PittDiabetes, Obesity & Metabolism|October 1, 2009
Future perspectives for insulinotropic agents in the treatment of type 2 diabetes-DPP-4 inhibitors and sulphonylureasB Gallwitz, H-U HäringDiabetes, Obesity & Metabolism|June 13, 2009
Management of hypertension in patients with diabetes: the place of angiotensin-II receptor blockersRigas Kalaitzidis, George BakrisDiabetes, Obesity & Metabolism|June 18, 2009
Maximal lipid oxidation in patients with type 2 diabetes is normal and shows an adequate increase in response to aerobic trainingM Mogensen, B F Vind, K Højlund, et al.Diabetes, Obesity & Metabolism|September 22, 2009
Effects of pioglitazone and rosiglitazone combined with metformin on body weight in people with diabetesG Derosa, C Tinelli, P MaffioliDiabetes, Obesity & Metabolism|April 13, 2010
Glycaemic variability and complications in patients with diabetes mellitus: evidence from a systematic review of the literatureL Nalysnyk, M Hernandez-Medina, G KrishnarajahDiabetes, Obesity & Metabolism|April 13, 2010
Pharmacological profiles of a novel protein tyrosine phosphatase 1B inhibitor, JTT-551S Fukuda, T Ohta, S Sakata, et al.Pageof 630